about
Posttransplant allosensitization in low immunological risk kidney and kidney-pancreas graft recipientsEnd-stage renal disease versus death in a Portuguese cohort of elderly patients: an approach using competing event analysis.Biomarkers and Imaging Findings of Anderson-Fabry Disease-What We Know Now.Kidney and anemia in familial amyloidosis type I.Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M.Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M.Chylous ascites in a renal transplant recipient under sirolimus (rapamycin) treatment.Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits.Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.Low erythropoietin production in familial amyloidosis TTR V30M is not related with renal congophilic amyloid deposition. A clinicopathologic study of twelve cases.Liver transplantation and anemia in familial amyloidosis ATTR V30MEnd-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factorsFamilial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathyTransthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer moleculeEnd-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry casesAnticipation of presbyopia in Portuguese familial amyloidosis ATTR V30MImpact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?The ever-growing understanding of transthyretin amyloidosis nephropathyImpact ofde novodonor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantationSerá Doença de Fabry? Abordagem Diagnóstica e de SeguimentoAnalysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantationProgressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: Clinical report of two siblingsCharacterization of End-Stage Renal Disease After Liver Transplantation in Transthyretin Amyloidosis (ATTR V30M)Combined liver–kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: nephrological assessmentEnd-stage renal disease in familial amyloidosis ATTR Val30MetRemission of proteinuria following liver transplantation for familial amyloid polyneuropathy TTR Met30
P50
Q33563056-47BE277B-24FD-4002-8ADC-C5461F730051Q38669268-1BDEFA72-884D-494E-A430-B1B35C9E0A59Q41297721-BF63BE50-00A7-4F90-9686-0198F718BB42Q43797007-FA0E9602-9DE5-4DF1-AE22-D45D2E6D944DQ44633965-14ABD35E-BEC9-4304-8C8E-C50A2E2BD8BFQ46313837-CAD782B7-C802-48D4-BC97-9989D1AF5684Q46511452-B27EEA53-8DC6-48F0-8EB8-95F80953BC94Q47957882-F4CF5C66-5CD2-4DD2-B506-99CA611DA363Q48255248-0D2EC365-BF13-45BD-B06A-FBB108568F08Q48290798-EC5FB3DA-3B8D-48DA-AF42-6F032D20819BQ54123131-9B5D6A54-BC40-4D0E-B7E4-A96EF08070ABQ57526247-DCA2AA0C-9E44-4216-8DB5-8BDCB0EC063EQ57526268-7C65927E-FE27-426F-A301-0FCF67788801Q57526276-4549B969-7C94-4CC3-8B2F-88F01F83179AQ58124903-7EE501A2-9CD2-4212-B33B-B102010E1841Q58124926-4EF32F77-6627-4F77-B363-FA8AC7782353Q58272458-94C35D07-A134-4869-A1A7-C41DF01F46B4Q61717658-64FE3141-5CDB-478C-A3E0-78564B2410BAQ61717663-6F2BD20B-C28A-42A0-B4DC-02134C83F847Q61717667-45147B8C-9CB0-4837-9D20-49A63B96E8ADQ61717669-88A7BACC-024A-40DB-BC3A-795FC838B70EQ61717674-1E624FC9-6964-410D-B871-B820091E29B2Q61717703-FF0B6458-34DE-4DDF-9543-CDF0A17083E6Q61717713-4E0F608E-462D-4E68-A91B-0D9CB44D98A8Q61717720-6A588C13-2B38-4138-8185-C4FE0E489C62Q61717740-044197B0-1A12-4739-B4DC-9F247EEA4B6CQ61717746-90A0D5BC-D1FE-4E34-A2EC-A90B31228FCD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Idalina Beirão
@ast
Idalina Beirão
@en
Idalina Beirão
@es
Idalina Beirão
@nl
Idalina Beirão
@sl
type
label
Idalina Beirão
@ast
Idalina Beirão
@en
Idalina Beirão
@es
Idalina Beirão
@nl
Idalina Beirão
@sl
prefLabel
Idalina Beirão
@ast
Idalina Beirão
@en
Idalina Beirão
@es
Idalina Beirão
@nl
Idalina Beirão
@sl
P106
P1153
6602220649
P21
P31
P496
0000-0003-3903-0170